Expression and purification of a recombinant buforin derivative from Escherichia coli
(2004) In Process Biochemistry 39(11). p.1731-1736- Abstract
- An Escherichia coli expression system was constructed for
production of a recombinant antimicrobial peptide buforin derivative
named buforin IIb and a large-scale process of cultivation and
purification was also developed. Inclusion bodies of fusion proteins
containing recombinant buforin IIb were released from
high-density-cultured cells by high-pressure homogenization. The
inclusion bodies solubilized in a buffer containing 8 M urea were incubated in cleavage buffer containing 1.7 M
hydroxylamine. The crude mixtures were fractionated by ammonium sulfate
precipitation and then washed with distilled water to remove salts. The
pellets were dissolved in 7 M urea solution, and treated with... (More) - An Escherichia coli expression system was constructed for
production of a recombinant antimicrobial peptide buforin derivative
named buforin IIb and a large-scale process of cultivation and
purification was also developed. Inclusion bodies of fusion proteins
containing recombinant buforin IIb were released from
high-density-cultured cells by high-pressure homogenization. The
inclusion bodies solubilized in a buffer containing 8 M urea were incubated in cleavage buffer containing 1.7 M
hydroxylamine. The crude mixtures were fractionated by ammonium sulfate
precipitation and then washed with distilled water to remove salts. The
pellets were dissolved in 7 M urea solution, and treated with
polyethyleneimine (PEI) to remove contaminated DNA. The recombinant
buforin IIb was purified by cation exchange chromatography and reverse
phase HPLC (RP-HPLC). The purity of the recombinant buforin IIb was
determined by RP-HPLC and SDS-PAGE and the molecular mass of the
recombinant buforin IIb analyzed by MALDI-TOF-MS showed good agreement
with the authentic buforin IIb. These results suggest that the
production method in this report is useful in obtaining a large quantity
of recombinant antimicrobial peptide. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/c8fb00a4-6ba6-4f84-bb51-8e356e8e8d2a
- author
- Pyo, Sang-Hyun LU ; Lee, Jae-Hyun ; Park, Heung-Bok ; Cho, Jin-Suk ; Kim, Hong-Rak ; Han, Byung-Hee and Park, Yeon-Sung
- publishing date
- 2004-07-30
- type
- Contribution to journal
- publication status
- published
- in
- Process Biochemistry
- volume
- 39
- issue
- 11
- pages
- 1731 - 1736
- publisher
- Elsevier
- external identifiers
-
- scopus:3042850735
- ISSN
- 1359-5113
- DOI
- 10.1016/j.procbio.2003.07.007
- language
- English
- LU publication?
- no
- id
- c8fb00a4-6ba6-4f84-bb51-8e356e8e8d2a
- date added to LUP
- 2025-09-05 17:54:58
- date last changed
- 2025-09-18 13:21:27
@article{c8fb00a4-6ba6-4f84-bb51-8e356e8e8d2a, abstract = {{An <em>Escherichia coli</em> expression system was constructed for <br> production of a recombinant antimicrobial peptide buforin derivative <br> named buforin IIb and a large-scale process of cultivation and <br> purification was also developed. Inclusion bodies of fusion proteins <br> containing recombinant buforin IIb were released from <br> high-density-cultured cells by high-pressure homogenization. The <br> inclusion bodies solubilized in a buffer containing 8 M urea were incubated in cleavage buffer containing 1.7 M<br> hydroxylamine. The crude mixtures were fractionated by ammonium sulfate<br> precipitation and then washed with distilled water to remove salts. The<br> pellets were dissolved in 7 M urea solution, and treated with <br> polyethyleneimine (PEI) to remove contaminated DNA. The recombinant <br> buforin IIb was purified by cation exchange chromatography and reverse <br> phase HPLC (RP-HPLC). The purity of the recombinant buforin IIb was <br> determined by RP-HPLC and SDS-PAGE and the molecular mass of the <br> recombinant buforin IIb analyzed by MALDI-TOF-MS showed good agreement <br> with the authentic buforin IIb. These results suggest that the <br> production method in this report is useful in obtaining a large quantity<br> of recombinant antimicrobial peptide.}}, author = {{Pyo, Sang-Hyun and Lee, Jae-Hyun and Park, Heung-Bok and Cho, Jin-Suk and Kim, Hong-Rak and Han, Byung-Hee and Park, Yeon-Sung}}, issn = {{1359-5113}}, language = {{eng}}, month = {{07}}, number = {{11}}, pages = {{1731--1736}}, publisher = {{Elsevier}}, series = {{Process Biochemistry}}, title = {{Expression and purification of a recombinant buforin derivative from <i>Escherichia coli</i>}}, url = {{http://dx.doi.org/10.1016/j.procbio.2003.07.007}}, doi = {{10.1016/j.procbio.2003.07.007}}, volume = {{39}}, year = {{2004}}, }